108 related articles for article (PubMed ID: 2667111)
1. Clinical efficacy of ciprofloxacin in lower respiratory tract infections.
Pedersen SS
Scand J Infect Dis Suppl; 1989; 60():89-97. PubMed ID: 2667111
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
[TBL] [Abstract][Full Text] [Related]
3. Role of fluoroquinolones in lower respiratory tract infections.
Vellend H
Clin Invest Med; 1989 Feb; 12(1):39-43. PubMed ID: 2920482
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
Louie TJ
CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis.
Stutman HR; Shalit I; Marks MI; Greenwood R; Chartrand SA; Hilman BC
Am J Med; 1987 Apr; 82(4A):142-5. PubMed ID: 3555028
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin: an update on clinical experience.
Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
8. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
Nix DE; DeVito JM
Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Lode H; Wiley E; Olschewski P; Sievers H; Wintermantel M; Baetz R; Lebahn K; Reinke M; Wagner J; Borner K
Scand J Infect Dis Suppl; 1990; 68():50-5. PubMed ID: 2218423
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.
Goldfarb J; Stern RC; Reed MD; Yamashita TS; Myers CM; Blumer JL
Am J Med; 1987 Apr; 82(4A):174-9. PubMed ID: 3555032
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
Kobayashi H
Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
Fass RJ
Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
[TBL] [Abstract][Full Text] [Related]
15. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
Nichols L; Maki DG
Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
[TBL] [Abstract][Full Text] [Related]
16. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
Mangiarotti P; Manara G; Bianchi L; Piccioni PD; Grassi C
G Ital Chemioter; 1989; 36(1-3):89-94. PubMed ID: 2488917
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of ciprofloxacin and other unrelated antimicrobials against bacterial respiratory tract pathogens.
Felmingham D; Robbins MJ; Baskerville AJ; Sanghrajka MD; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1989; 15(2):59-62. PubMed ID: 2737080
[TBL] [Abstract][Full Text] [Related]
18. Focus on oral ciprofloxacin; clinical and economic considerations.
Pastel D
Hosp Pharm; 1989 Oct; 24(10):814-20, 823-6, 842. PubMed ID: 10295899
[TBL] [Abstract][Full Text] [Related]
19. [The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):208-11. PubMed ID: 10072803
[TBL] [Abstract][Full Text] [Related]
20. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.
Nix DE; Sands MF; Peloquin CA; Vari AJ; Cumbo TJ; Vance JW; Fracasso JE; Schentag JJ
Am J Med; 1987 Apr; 82(4A):352-6. PubMed ID: 3555060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]